Sadhna Sharma

1.5k total citations · 1 hit paper
39 papers, 1.3k citations indexed

About

Sadhna Sharma is a scholar working on Infectious Diseases, Immunology and Molecular Biology. According to data from OpenAlex, Sadhna Sharma has authored 39 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 17 papers in Immunology and 15 papers in Molecular Biology. Recurrent topics in Sadhna Sharma's work include Tuberculosis Research and Epidemiology (26 papers), Mycobacterium research and diagnosis (7 papers) and vaccines and immunoinformatics approaches (6 papers). Sadhna Sharma is often cited by papers focused on Tuberculosis Research and Epidemiology (26 papers), Mycobacterium research and diagnosis (7 papers) and vaccines and immunoinformatics approaches (6 papers). Sadhna Sharma collaborates with scholars based in India, Italy and Austria. Sadhna Sharma's co-authors include Margit Pavelka, F Oberhammer, A F Purchio, Wilfried Bursch, Rolf Schulte‐Hermann, Monika Sharma, Swati Singh, Sugata Roy, Mridula Bose and Saurabh Varma and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Orthopaedics and Related Research and Journal of Ethnopharmacology.

In The Last Decade

Sadhna Sharma

38 papers receiving 1.3k citations

Hit Papers

Induction of apoptosis in... 1992 2026 2003 2014 1992 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sadhna Sharma India 16 584 437 421 266 217 39 1.3k
Yawen Wang China 19 349 0.6× 230 0.5× 355 0.8× 224 0.8× 147 0.7× 79 1.2k
David W. A. Beno United States 21 491 0.8× 180 0.4× 294 0.7× 186 0.7× 161 0.7× 54 1.4k
Heike Bantel Germany 18 586 1.0× 156 0.4× 408 1.0× 318 1.2× 96 0.4× 32 1.4k
Myoung-Kuk Jang South Korea 9 708 1.2× 105 0.2× 454 1.1× 228 0.9× 296 1.4× 14 1.2k
Yuan Hu China 20 526 0.9× 216 0.5× 568 1.3× 150 0.6× 88 0.4× 67 1.3k
Hitomi Nakamura Japan 20 284 0.5× 139 0.3× 516 1.2× 221 0.8× 107 0.5× 70 1.3k
Alonso Heredia United States 23 320 0.5× 609 1.4× 413 1.0× 435 1.6× 135 0.6× 71 1.6k
Isabel Ojanguren Spain 24 301 0.5× 224 0.5× 756 1.8× 144 0.5× 311 1.4× 53 1.6k
Kyoko Sakai Japan 18 267 0.5× 223 0.5× 329 0.8× 379 1.4× 97 0.4× 44 1.4k

Countries citing papers authored by Sadhna Sharma

Since Specialization
Citations

This map shows the geographic impact of Sadhna Sharma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sadhna Sharma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sadhna Sharma more than expected).

Fields of papers citing papers by Sadhna Sharma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sadhna Sharma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sadhna Sharma. The network helps show where Sadhna Sharma may publish in the future.

Co-authorship network of co-authors of Sadhna Sharma

This figure shows the co-authorship network connecting the top 25 collaborators of Sadhna Sharma. A scholar is included among the top collaborators of Sadhna Sharma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sadhna Sharma. Sadhna Sharma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sharma, Sadhna, Gaurav Joshi, Snigdha Singh, et al.. (2025). Design and synthesis of new 1,4-naphthoquinones appended sulfenylated thiazoles as cyclooxygenase II inhibitors: Exploring the utility in the development of anticancer agents. Bioorganic Chemistry. 161. 108537–108537. 3 indexed citations
2.
Bedi, Arjun S., et al.. (2025). Association of Latent Tuberculosis and Vitamin D Levels in Young Individuals: An Exploratory Study. International Journal of Mycobacteriology. 14(1). 66–72.
3.
Sharma, Sadhna, et al.. (2024). Mycobacterium tuberculosis protein PPE15 (Rv1039c) possesses eukaryote-like SH3 domain that interferes with NADPH Oxidase assembly and Reactive Oxygen Species production. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(4). 119702–119702. 2 indexed citations
4.
Sharma, Sadhna, et al.. (2024). Role of PE/PPE proteins of Mycobacterium tuberculosis in triad of host mitochondria, oxidative stress and cell death. Microbial Pathogenesis. 193. 106757–106757. 3 indexed citations
5.
Sharma, Sadhna, et al.. (2024). C-terminal region of Rv1039c (PPE15) protein of Mycobacterium tuberculosis targets host mitochondria to induce macrophage apoptosis. APOPTOSIS. 29(9-10). 1757–1779. 2 indexed citations
6.
Sharma, Sadhna, et al.. (2023). PE_PGRS45 (Rv2615c) protein of Mycobacterium tuberculosis perturbs mitochondria of macrophages. Immunology and Cell Biology. 101(9). 829–846. 5 indexed citations
7.
Sharma, Monika, et al.. (2022). Mycobacterium tuberculosis dormancy regulon proteins Rv2627c and Rv2628 as Toll like receptor agonist and as potential adjuvant. International Immunopharmacology. 112. 109238–109238. 9 indexed citations
8.
9.
Joshi, Hemant, et al.. (2022). Elucidating the function of hypothetical PE_PGRS45 protein of Mycobacterium tuberculosis as an oxido-reductase: a potential target for drug repurposing for the treatment of tuberculosis. Journal of Biomolecular Structure and Dynamics. 41(19). 10009–10025. 3 indexed citations
10.
Sharma, Sadhna, et al.. (2021). Design of a peptide-based vaccine from late stage specific immunogenic cross-reactive antigens of PE/PPE proteins of Mycobacterium tuberculosis. European Journal of Pharmaceutical Sciences. 168. 106051–106051. 10 indexed citations
11.
Sharma, Sadhna, et al.. (2021). Proline-Glutamate/Proline-Proline-Glutamate (PE/PPE) proteins of Mycobacterium tuberculosis: The multifaceted immune-modulators. Acta Tropica. 222. 106035–106035. 20 indexed citations
13.
Singh, Swati, et al.. (2017). Mycobacterium tuberculosis MymA is a TLR2 agonist that activate macrophages and a T H 1 response. Tuberculosis. 106. 16–24. 12 indexed citations
14.
Misra, Richa, et al.. (2016). Characterization of MymA protein as a flavin‐containing monooxygenase and as a target of isoniazid. Chemical Biology & Drug Design. 89(1). 152–160. 5 indexed citations
15.
Sharma, Monika, et al.. (2016). Predicting promiscuous antigenic T cell epitopes of Mycobacterium tuberculosis mymA operon proteins binding to MHC Class I and Class II molecules. Infection Genetics and Evolution. 44. 182–189. 11 indexed citations
16.
Mishra, Ruchi, Mrinal Kumar Das, Savita Singh, et al.. (2016). Articulatin-D induces apoptosis via activation of caspase-8 in acute T-cell leukemia cell line. Molecular and Cellular Biochemistry. 426(1-2). 87–99. 15 indexed citations
17.
Singh, Swati, et al.. (2014). Cell wall-associated Mycobacterium tuberculosis rRv3083 protein stimulates macrophages through toll-like receptor-2 (TLR2). International Journal of Mycobacteriology. 4. 176–176. 2 indexed citations
18.
Singh, Swati, et al.. (2013). Immunogenic potential of latency associated antigens against Mycobacterium tuberculosis. Vaccine. 32(6). 712–716. 57 indexed citations
19.
Oberhammer, F, Margit Pavelka, Sadhna Sharma, et al.. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1.. Proceedings of the National Academy of Sciences. 89(12). 5408–5412. 604 indexed citations breakdown →
20.
Sharma, Sadhna, et al.. (1979). T and B lymphocytes and blastogenesis in leprosy.. PubMed. 51(2). 194–202. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026